Pathophysiology and Epidemiology of Portal Hypertension Hidemasa OkumuraTakumi AramakiYasumi Katsuta Section 1 23 October 2012 Pages: 2 - 12
Morbidity and Mortality of Portal Hypertension Joanna B. ReadyWilliam G. Rector Section 1 23 October 2012 Pages: 13 - 24
Surgery and Sclerotherapy for Treatment of Portal Hypertension and Oesophageal Varices A. K. Burroughs Section 1 23 October 2012 Pages: 25 - 29
A Randomised Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis Didier LebrecThierry PoynardJean-Pierre Benhamou Section 1 23 October 2012 Pages: 30 - 34
β Blockers in the Secondary Prevention of Gastrointestinal Haemorrhage in Well-Compensated Cirrhotics M. TommasiniR. de FranchisM. Colombo Section 2 23 October 2012 Pages: 35 - 41
Comparison of Propranolol with Injection Sclerotherapy in Prevention of Rebleeding from Oesophageal Varices in Cirrhotic Patients David WestabyR. PolsonRoger Williams Section 1 23 October 2012 Pages: 42 - 46
A Randomised Controlled Trial of Propranolol for the Prevention of Initial Bleeding in Cirrhotic Patients with Portal Hypertension Luigi PagliaroLinda PastaGennaro D’Amico Section 2 23 October 2012 Pages: 48 - 51
Propranolol in the Primary Prevention of Upper Gastrointestinal Tract Haemorrhage in Patients with Cirrhosis of the Liver and Oesophageal Varices Jean-Pierre PascalPaul Calès Section 2 23 October 2012 Pages: 52 - 61
β-Blockers in Portal Hypertension J. A. LewisJ. M. DavisH. A. Cameron Section 2 23 October 2012 Pages: 62 - 69
